Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
36.37 USD | +7.38% | +10.89% | +67.31% |
01:19pm | Baird Starts Spyre Therapeutics With Outperform Rating, $50 Price Target | MT |
Apr. 19 | Sector Update: Health Care Stocks Steady Pre-Bell Friday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.31% | 1.36B | |
-1.34% | 104B | |
+4.47% | 97.47B | |
+5.76% | 22.25B | |
-12.99% | 21.68B | |
-9.30% | 18.2B | |
-39.98% | 17.02B | |
-11.32% | 16.36B | |
+7.92% | 14.39B | |
+40.13% | 12.37B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares